Business & Consumer Services » Business Services | Calmare Therapeutics Inc.

Calmare Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Sales/Revenue
912.50
771.90
1,163.60
891.50
1,168.90
Cost of Goods Sold (COGS) incl. D&A
366.40
272.70
440.70
279.70
317.30
Gross Income
546.10
499.10
723.00
611.80
851.60
SG&A Expense
3,571.10
3,019.90
2,952.80
3,414.60
3,246.00
EBIT
3,025.00
2,520.70
2,229.80
2,802.80
2,394.40
Unusual Expense
53.70
58.50
181.90
2.60
-
Non Operating Income/Expense
157.20
-
-
104.10
-
Interest Expense
82.60
210.00
999.20
976.80
1,434.20
Pretax Income
3,004.10
2,672.20
3,410.90
3,678.10
3,828.60
Consolidated Net Income
3,004.10
2,672.20
3,410.90
3,678.10
3,828.60
Net Income
3,004.10
2,672.20
3,410.90
3,678.10
3,828.60
Net Income After Extraordinaries
3,004.10
2,672.20
3,410.90
3,678.10
3,828.60
Net Income Available to Common
3,004.10
2,672.20
3,410.90
3,678.10
3,828.60
EPS (Basic)
0.20
0.16
0.15
0.13
0.13
Basic Shares Outstanding
15,007.90
16,977.00
23,513.90
27,885.20
28,715.00
EPS (Diluted)
0.20
0.16
0.15
0.13
0.13
Diluted Shares Outstanding
15,007.90
16,977.00
23,513.90
27,885.20
28,715.00
EBITDA
3,010.40
2,509.60
2,212.20
2,786.30
2,377.90

About Calmare Therapeutics

View Profile
Address
1375 Kings Highway East
Fairfield Connecticut 06824
United States
Employees -
Website http://www.calmaretherapeutics.com
Updated 07/08/2019
Calmare Therapeutics, Inc. is a medical device company, which develops and distributes products and technologies for chronic neuropathic pain and wound care affliction patients. Its product device, Calmare Pain Therepy Device, is non-invasive and non-addictive modality that treats chronic, neuropathic pain. The company was founded in 1968 and is headquartered in Fairfield, CT.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.